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Abstract Increases in choline containing metabolites have been
associated with a number of disorders, including malignant cell
growth. In this study, high resolution magic angle spinning 1H
nuclear magnetic resonance spectroscopy was employed to
monitor metabolite changes during cell transfection, and an
increase in phosphocholine was detected. This increase appears to
be correlated with cell membrane disruption associated with the
insertion of plasmid DNA into cells, since the level of
phosphocholine in mock transfected cells was comparable to
that of control cells. These data suggest choline containing
metabolite changes detected in vivo using magnetic resonance
spectroscopy relate to cell membrane disruption. ß 2001 Fed-
eration of European Biochemical Societies. Published by Elsev-
ier Science B.V. All rights reserved.
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1. Introduction
Increased resonance intensities of choline containing metab-
olites have been associated with a number of pathologies us-
ing 1H magnetic resonance spectroscopy (MRS) in vivo, in-
cluding tumour growth, multiple sclerosis, Duchenne
muscular dystrophy and AIDS dementia [1^4]. However, 1H
MRS in vivo has poor spectral resolution and it is not possi-
ble to distinguish between di¡erent choline containing metab-
olites.
High resolution 1H nuclear magnetic resonance (NMR)
spectra of cell extracts does distinguish between the singlets
associated with choline (N 3.20), phosphocholine (N 3.23), glyc-
erophosphocholine (N 3.26) and phosphatidylcholine (N 3.30),
and Bhakoo and co-workers have used this methodology to
detect increases in the ratio of phosphocholine to glycerophos-
phocholine in aqueous extracts of cancerous cell lines [5].
These data suggest that the increased levels of choline con-
taining metabolites commonly detected in MRS studies may
be associated with aqueously soluble pools. However, one
caveat is that spectra of extracts re£ect the relative solubilities
of the metabolites within an extraction media as well as the
tissue content of the metabolite. Further support that MRS
detects predominantly cytosolic choline and its derivatives
arises from the chemical environment that cell membrane me-
tabolites occur within. These molecules experience large di-
pole^dipole couplings caused by their restricted environment,
broadening resonances, with dipolar couplings being of the
order of 50 kHz in lipid bilayers [6]. Thus, cell membrane
bound choline would produce a broad component, poorly
detectable above the baseline in most spectra obtained in
vivo. Furthermore, spectra obtained in vivo often rely on T2
editing to remove resonances from molecules within con-
strained environments, such as cell membranes.
High resolution magic angle spinning (HRMAS) 1H NMR
spectroscopy produces high resolution spectra of intact tissue,
circumventing the need to extract metabolites [7^9]. The tech-
nique is particularly e¡ective at distinguishing malignant tis-
sue from benign growths, as demonstrated in renal tissue [10],
the brain [7], adipocytes [8,11] and prostate tissue [9]. In these
studies, cancerous tissue was in part characterised by in-
creased choline containing metabolites, suggesting that these
compounds are biomarkers for cell membrane manufacture
and uncontrolled cell growth. However, unlike solid state
MAS NMR spectroscopy, the modest rotation speeds used
in HRMAS 1H NMR spectroscopy (6 6000 Hz) are less
than the dipole^dipole interactions of the cell membrane [6],
and hence, membrane bound choline containing metabolites
are expected to be poorly observed.
Here we demonstrate the use of HRMAS 1H NMR spec-
troscopy as an ideal technique to readily follow metabolic
changes in intact cells expressing a recombinant protein fol-
lowing transfection. We also show that the relative intensity of
phosphocholine increases in the HRMAS 1H NMR spectra of
such cells, and suggest an explanation for the increased levels
of choline containing metabolites in the 1H MRS spectra of
many diverse pathological conditions.
2. Materials and methods
2.1. Mammalian expression system and transfection
The T-Rex1 mammalian expression system [12] was used. The
tetracycline repressor expression vector (pcDNA6/TR) stably trans-
formed in the rat hepatoma McRH7777 cell line was a kind gift
from Drs Boren and Gustafsson (Wallenberg Laboratory, Goteborg
University, S-41345 Goteborg, Sweden). The lacZ gene, pcDNA4/TO/
lacZ, and the Calcium Phosphate Transfection kit were obtained from
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Invitrogen. Cells were grown in DMEM containing 20% fetal calf
serum, 2 mM L-glutamine, 2 mM sodium pyruvate, 100 U/ml peni-
cillin, 100 Wg/ml streptomycin, and 3 Wg/ml blasticidin. In all, there
were ¢ve groups of cells ; control cells (untreated, n = 3), mock trans-
fected (Ca2 treatment only, n = 4), mock transfected+tetracycline
(n = 4), transfected with pcDNA4/TO (n = 2) or pcDNA4/TO/lacZ
(n = 4). Transfections were performed as recommended by Invitrogen,
in the absence and presence of pcDNA4/TO or pcDNA4/TO/lacZ (30
Wg/1U106 cells). Tetracycline was added to the media (1 mg/ml) of
transfected cells after an overnight incubation. Sixty ¢ve hours post-
transfection, cells were harvested in phosphate-bu¡ered saline, exten-
sively washed and snap-frozen in liquid nitrogen. The e⁄ciency of
transfection was veri¢ed by L-galactosidase staining.
2.2. HRMAS 1H NMR spectroscopy
Cells (0.5U106) were extensively washed in 0.9% NaCl in D2O, and
resuspended in 50 Wl of this solution. Cells were pipetted into a 4 mm
outer diameter zirconium oxide rotor, and the rotor ¢lled with V10
Wl D2O spiked with 10 mM TSP. Rotors were inserted into a high
resolution 1H^13C-MAS probe interfaced with an AVANCE spec-
trometer and a 9.6 T superconducting magnet (Bruker GmbH, Karls-
ruhe, Germany). HRMAS 1H NMR spectra were acquired at the
magic angle (54.7‡) and 300 K with a rotor spin speed of 4 kHz.
Solvent suppressed and T2 edited Carr^Purcell^Meiboom^Gill
(CPMG) spectra were acquired with 256 scans, into 64 k data points
across a spectral width of 6410.3 Hz, using a relaxation delay of 2 s
[13]. For the acquisition of CPMG spectra, a total spin^echo delay of
42 ms was used. Line-broadening apodisation function of 1.0 Hz was
applied to all HRMAS 1H NMR FIDs prior to Fourier transforma-
tion. Spectra were analysed using standard Bruker software (XWIN-
NMR version 2.5). Assignments were made using literature values
[8,11] and using 1H^1H correlation spectroscopy.
Spectra were initially compared visually. Following this, principle
component analysis (PCA) and partial least squares-discriminant
analysis (PLS-DA) was applied to the spectra to identify patterns of
variation resulting from the treatments [14]. 1H NMR spectra of the
cell culture media acquired using a standard £ow probe and the sol-
vent pre-saturation pulse sequence described above were similarly
compared using pattern recognition.
Results are presented as means þ standard error of the mean and
were compared using Student’s t-test and the ANOVA test for var-
iance with a Tukey post-test within Instat (Graphpad Inc., CA, USA).
3. Results and discussion
HRMAS 1H NMR spectroscopy of the McRH7777 cell line
stably transformed with the tetracycline repressor expression
vector (pcDNA6/TR) produced spectra of a resolution (Fig.
1) comparable with those previously obtained from aqueous
extracts of cancerous cell lines [5], despite the relatively small
number of cells (0.5U106) used. To examine the impact of
transfection on cell metabolites on this cell line during tran-
sient transfection experiments, we performed a mock trans-
fection. No metabolic changes were observed, including the
resonance intensities of phosphocholine or choline (Table 1).
Further, when the mock transfected cells were treated with
tetracycline, as would be required to induce gene expression
in the expression system used, the spectra were comparable to
control cells. This was con¢rmed using both PCA and PLS-
DA methods of pattern recognition.
Next, we examined the impact of transfecting the T-Rex
inducible vector pcDNA4/TO/lacZ into the stably trans-
formed McRH7777 cells. A signi¢cant increase in phospho-
choline, relative to the resonance intensity of glycine, was
detected (Fig. 2). This was independent of the transcription
of the LacZ gene as these changes were also observed when
the LacZ gene was absent from the plasmid vector. The phos-
phocholine and choline resonances were in a relatively unre-
stricted environment, and readily observable in T2 weighted
CPMG spectra (Table 1). PLS-DA also demonstrated that
transient transfection of pcDNA4/TO/lacZ DNA into our
cell system produced an increased resonance from phospho-
choline (Fig. 3). This resonance was associated with an in-
crease in PLS factor t3 and a decrease in factor t1. These
factors had a combined Q2 = 0.43 for the goodness of ¢t to
the predicted model, and the changes were correlated with a
decrease in CH2CH2, CH3CH2 and CHNCHCH2CH2 lipid
moieties detected within the cells. However, these changes
were the only di¡erences in the spectra that separated the
transfected cells (i.e. those receiving plasmid DNA) from the
mock transfected cells, and control cells. PCA of spectra ob-
Fig. 1. HRMAS 1H NMR spectrum of intact mock transfected cells
showing aliphatic region using a conventional solvent suppressed
pulse sequence. Key: (1) Cholesterol, (2) CH3CH2- lipid, (3) isoleu-
cine, (4) leucine, (5) valine, (6) ethanol, (7) CH2CH2CH2 lipid, (8)
lactate, (9) CH2CH2CH2 lipid (extracellular?), (10) alanine, (11)
CH2CH2CO lipid, (12) CH2CH2C = C lipid, (13) acetate, (14) gluta-
mate/glutamine, (15) glutamate, (16) glutamine, (17) CH2CO, (18)
glutathione, (19) lysine, (20) citrate, (21) choline, (22) phosphocho-
line, (23) glycerophosphocholine/phosphatidylcholine, (24) taurine,
(25) glycine, (26) choline/phosphocholine/phosphatidylcholine, (27)
creatine, (28) glucose/sugars containing region.
Table 1
Metabolite ratios for integrals relative to the glycine resonance at N 3.56 for the cell treatment groups
Control
(n = 3)
Mock transfected
(n = 4)
Mock transfected and
tetracycline (n = 3)
Transfected with
pcDNA4/TO (n = 2)
Transfected with
pcDNA4/TO/lacZ (n = 4)
Phosphocholine (1) 1.43 þ 0.41 1.41 þ 0.43 1.26 þ 0.56 5.12 þ 1.30*;2;V 5.84 þ 0.64***;22;VV
Choline (1) 0.63 þ 0.45 1.27 þ 0.31 0.73 þ 0.23 0.85 þ 0.33 1.10 þ 0.25
Phosphocholine (2) 1.52 þ 0.56 1.47 þ 0.56 2.46 þ 0.57 5.33 þ 0.95*;2;V 5.62 þ 0.61**;2;V
Choline (2) 0.63 þ 0.37 1.84 þ 0.81 1.87 þ 0.25 1.10 þ 0.45 1.04 þ 0.26
The resonances at N 3.21 and N 3.23 for choline and phosphocholine, respectively, were used for the ratios. Ratios are included for both pulse
sequences used: (1) conventional solvent pre-saturation, (2) CPMG pulse sequence. *P6 0.01, **P6 0.01 and ***P6 0.005 for di¡erence be-
tween control cells and treated cells, 2P6 0.05 and 22P6 0.01 for di¡erence between mock transfected and other groups, VP6 0.05 and
VVP6 0.01 for di¡erence between mock transfected and tetracycline using Tukey post-test following ANOVA test of variance
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tained from the cell culture media failed to separate the cells
into treatment groups, indicating there were no metabolic
changes within the media. This indicates that £ux into and
out of the cells was the same for all ¢ve groups.
Transfection of cells relies on the membrane being made
permeable to the transfection vector by electroporation or
chemicals such as calcium phosphate, DEAE-dextran or
DMSO [15]. All of the cells examined in this study were
treated with Ca2 apart from the control group. This suggests
that the increase in phosphocholine observed in transfected
cells is speci¢c to transfection with a plasmid vector. As we
know of, no mechanism where DNA replication can cause a
change in phosphocholine metabolism and similar cell counts
were used in these experiments, thus, it seems reasonable to
imply that the changes in phosphocholine are caused by extra
cell membrane disruption by the plasmid vector. Furthermore,
the increased phosphocholine detected in these transfected
cells was most likely released from the ‘1H MRS poorly visi-
ble’ cell membrane into the ‘1H MRS visible’ cytosol, as the
spinning speeds involved were not great enough to resolve cell
membrane lipids, and no di¡erence in in£ux/e¥ux of cell me-
dia metabolites were detected. We have also noted increases in
phosphocholine following the addition of DMSO to stable cell
lines (data not shown), further supporting our hypothesis that
the increased resonance intensity of phosphocholine in trans-
fected cells detected in this study is caused by cell membrane
disruption. Intriguingly, the increase resonance intensity of
phosphocholine was not accompanied by an increase in the
resonance intensity of choline. This suggests that the cell
membrane disruption e¡ects phosphocholine more greatly,
possibly caused by the molecules more polar nature.
It was not possible to reliably estimate the resonance inten-
sities of glycerophosphocholine or phosphatidylcholine within
these cells as these resonances were very broad, presumably
caused by residual dipolar couplings which were not removed
by the process of spinning. Weybright and co-workers [16]
observed two lipid environments within adipocyte cells using
gradient HRMAS spectroscopy, suggesting one set to be
freely moving within the intracellular space, and the other in
a more restricted environment. This study also used modest
spin speeds, insinuating that while certain lipids may di¡use
slowly, they still possess a high degree of rotational motion in
order to be visible at slow spin speeds.
The results from this study suggest that increased detection
of choline containing metabolites during MRS in vivo, espe-
cially in malignant tissue [17], may correlate not with choline
synthesis [5] or cellular proliferation [1,18] but with a change
in the distribution of the metabolites caused by cell membrane
disruption. Correlating increases in the NMR detectability of
choline containing metabolites with cell membrane disruption
also may explain why a number of studies concerning non-
cancerous pathologies have detected rises in choline contain-
ing metabolites. In multiple sclerosis, increased choline detec-
tion [2] may result from demyelination altering neuronal cell
membrane integrity. Similarly, increases in the detectability of
choline metabolites in the brains of su¡erers of Duchenne
muscular dystrophy [3] and related animals models [19,20]
may correlate with reduced cell membrane integrity caused
by a failure to express dystrophin, a protein known to stabi-
lise the cell membrane.
Acknowledgements: J.L.G. is a Royal Society University Research
Fellow.
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